Free Trial

Spectral AI (MDAI) Competitors

Spectral AI logo
$2.60 -0.11 (-4.06%)
Closing price 07/25/2025 04:00 PM Eastern
Extended Trading
$2.65 +0.05 (+1.92%)
As of 07/25/2025 07:29 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MDAI vs. NYXH, XAIR, SMTI, STIM, ZIMV, SKIN, TCMD, BWAY, NVRO, and MGRM

Should you be buying Spectral AI stock or one of its competitors? The main competitors of Spectral AI include Nyxoah (NYXH), Beyond Air (XAIR), Sanara MedTech (SMTI), Neuronetics (STIM), ZimVie (ZIMV), Beauty Health (SKIN), Tactile Systems Technology (TCMD), Brainsway (BWAY), Nevro (NVRO), and Monogram Orthopaedics (MGRM). These companies are all part of the "medical equipment" industry.

Spectral AI vs. Its Competitors

Spectral AI (NASDAQ:MDAI) and Nyxoah (NASDAQ:NYXH) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, valuation, profitability, media sentiment, earnings, dividends, analyst recommendations and institutional ownership.

In the previous week, Spectral AI and Spectral AI both had 1 articles in the media. Spectral AI's average media sentiment score of 1.87 equaled Nyxoah'saverage media sentiment score.

Company Overall Sentiment
Spectral AI Very Positive
Nyxoah Very Positive

Spectral AI has higher revenue and earnings than Nyxoah. Spectral AI is trading at a lower price-to-earnings ratio than Nyxoah, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Spectral AI$29.58M2.23-$15.31M-$0.54-4.81
Nyxoah$4.89M52.80-$64.10M-$2.13-3.56

Spectral AI has a net margin of -30.75% compared to Nyxoah's net margin of -1,571.39%. Spectral AI's return on equity of 0.00% beat Nyxoah's return on equity.

Company Net Margins Return on Equity Return on Assets
Spectral AI-30.75% N/A -11.37%
Nyxoah -1,571.39%-63.37%-46.67%

Spectral AI has a beta of 0.9, meaning that its share price is 10% less volatile than the S&P 500. Comparatively, Nyxoah has a beta of 1.62, meaning that its share price is 62% more volatile than the S&P 500.

67.1% of Spectral AI shares are owned by institutional investors. 30.7% of Spectral AI shares are owned by insiders. Comparatively, 17.1% of Nyxoah shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Spectral AI presently has a consensus price target of $4.75, suggesting a potential upside of 82.69%. Nyxoah has a consensus price target of $14.50, suggesting a potential upside of 91.29%. Given Nyxoah's higher possible upside, analysts plainly believe Nyxoah is more favorable than Spectral AI.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Spectral AI
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
3.33
Nyxoah
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

Spectral AI beats Nyxoah on 10 of the 15 factors compared between the two stocks.

Get Spectral AI News Delivered to You Automatically

Sign up to receive the latest news and ratings for MDAI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MDAI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MDAI vs. The Competition

MetricSpectral AIMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$68.61M$6.85B$5.70B$9.50B
Dividend YieldN/A1.27%4.60%4.01%
P/E Ratio-4.8125.4528.1020.05
Price / Sales2.2364.09429.3789.38
Price / CashN/A20.5536.2258.56
Price / Book-8.134.758.665.87
Net Income-$15.31M$176.14M$3.25B$258.55M
7 Day Performance3.59%2.92%4.22%3.73%
1 Month Performance22.07%3.23%10.51%11.75%
1 Year Performance45.25%7.28%34.40%18.03%

Spectral AI Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MDAI
Spectral AI
3.5169 of 5 stars
$2.60
-4.1%
$4.75
+82.7%
+46.9%$68.61M$29.58M-4.8183
NYXH
Nyxoah
2.523 of 5 stars
$7.84
+3.7%
$14.50
+84.9%
-10.6%$267.03M$4.36M-3.68110Positive News
XAIR
Beyond Air
4.4725 of 5 stars
$3.05
-11.6%
$1.50
-50.8%
-74.5%$263.43M$3.70M-3.8670Analyst Upgrade
High Trading Volume
SMTI
Sanara MedTech
2.0107 of 5 stars
$28.87
-0.7%
$49.50
+71.5%
-20.7%$256.65M$86.67M-21.5460Positive News
High Trading Volume
STIM
Neuronetics
1.4932 of 5 stars
$3.86
+8.1%
$5.50
+42.5%
+137.6%$255.19M$74.89M-2.95180Positive News
ZIMV
ZimVie
0.5308 of 5 stars
$8.93
-0.8%
$16.33
+82.9%
-13.8%$248.67M$443.55M-12.581,770News Coverage
Analyst Upgrade
SKIN
Beauty Health
0.2077 of 5 stars
$1.87
-2.1%
$1.42
-24.2%
-1.6%$235.61M$322.47M-4.561,030Gap Up
TCMD
Tactile Systems Technology
3.6431 of 5 stars
$10.04
+0.8%
$16.00
+59.4%
-18.3%$233.43M$292.98M15.211,037Positive News
BWAY
Brainsway
2.7702 of 5 stars
$12.23
-0.6%
$14.25
+16.5%
+53.3%$231.15M$41.02M61.15120Positive News
NVRO
Nevro
N/A$5.85
+0.1%
$5.36
-8.3%
-40.8%$224.32M$408.52M-3.091,090
MGRM
Monogram Orthopaedics
1.0841 of 5 stars
$5.87
+78.4%
$5.40
-8.0%
+126.3%$209.49MN/A-13.0428Gap Up
High Trading Volume

Related Companies and Tools


This page (NASDAQ:MDAI) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners